New gene editing technique turns human pluripotent stem cells into a model system for polycystic kidney disease

By linking CRISPR/Cas9 with another cutting edge technology--human pluripotent stem cells (hPSCs)--researchers have used CRISPR/Cas9 to guide hPSCs into becoming a human cell-based lab model system for polycystic kidney disease (PKD).